NCT02630875 - A4250, an IBAT Inhibitor in Pediatric Cholestasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 17, 2017

Study Completion Date

March 17, 2017

Conditions

Pediatric Cholestasis

Interventions

DRUG

A4250

Trial Locations (7)

Henrik Arnell, Stockholm

Department of Pediatric and Adolescent Medicine Rigshospitalet, Copenhagen

Pediatric Hepatology and Liver Transplantation, University Hospitals of Paris-Sud, Paris

Department of Pediatric Gastroenterology Hepatology-Nutrition, Necker-Enfants maladies hospital, Paris

Pediatric Gastroenterology and Hepatology, Pediatric Surgery, Hannover, Hanover

Gastroenterology/Hepatology, University Hospital for Children and Adolescents, Tübingen

King's College Hospital NHS Foundation Trust, London